Editorial

Engaging the private sector to improve antimicrobial use in the community

Luh Putu Lila Wulandari , Virginia Wiseman

Luh Putu Lila Wulandari
The Kirby Institute, University of New South Wales Department of Public Health and Preventive Medicine, Faculty of Medicine, Udayana University. Email: putuwulandari@gmail.com

Virginia Wiseman
The Kirby Institute, University of New South Wales London School of Hygiene & Tropical Medicine
Online First: December 01, 2018 | Cite this Article
Wulandari, L., Wiseman, V. 2018. Engaging the private sector to improve antimicrobial use in the community. Public Health and Preventive Medicine Archive 6(2): 79-81. DOI:10.15562/phpma.v6i2.187


Antimicrobial resistance (AMR) is one of the world’s most pressing public health threats. It increases the cost of health care through longer duration of illness and hospital stays, additional tests, and the need for more expensive drugs.AMR refers to the ability of a microorganism to stop an antimicrobial (such as an antibiotic, antiviral or antimalarial) from working against it. As a consequence of AMR, standard treatments become ineffective, and infections persist and may spread to others. The impact of AMR is far-reaching and equates to the situation before the discovery of antibiotics, when even small infections were difficult, or very often impossible to treat, and medical procedures too risky to perform due to the potential of untreatable infection.

References

Maragakis LL, Perencevich EN, Cosgrove SE. Clinical and economic burden of antimicrobial resistance. Expert Review of Anti-infective Therapy. 2008;6(5):751-63.

Hawkey PM. The growing burden of antimicrobial resistance. Journal of Antimicrobial Chemotherapy. 2008;62(suppl_1):i1-i9.

O'Neil J. Review on antimicrobial resistance. Tackling drug resistant infections globally: final report and recommendations.; 2016.

Chereau F, Opatowski L, Tourdjman M, Vong S. Risk assessment for antibiotic resistance in South East Asia. BMJ. 2017;358.

Holloway KA, Kotwani A, Batmanabane G, Puri M, Tisocki K. Antibiotic use in South East Asia and policies to promote appropriate use: reports from country situational analyses. BMJ. 2017;358.

Teng CL. Antibiotic prescribing for upper respiratory tract infections in the Asia-Pacific region: A brief review. Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia. 2014;9(2):18-25.

World Health Organization. Medicines use in primary care in developing and transitional countries Fact Book summarizing results from studies reported between 1990 and 2006. 2009.

McKay R, Mah A, Law MR, McGrail K, Patrick DM. Systematic Review of Factors Associated with Antibiotic Prescribing for Respiratory Tract Infections. Antimicrobial Agents and Chemotherapy. 2016;60(7):4106.

Radyowijati A, Haak H. Determinants of Antimicrobial Use in the Developing World. 2002.

Tangcharoensathien V, Chanvatik S, Sommanustweechai A. Complex determinants of inappropriate use of antibiotics. Bulletin of the World Health Organization. 2018;96(2):141-4.

Radyowijati A, Haak H. Improving antibiotic use in low-income countries: an overview of evidence on determinants. Social Science & Medicine. 2003;57(4):733-44.

World Health Organization Regional Office for South-East Asia. Jaipur declaration on antimicrobial resistance. . 2011.

G20 Health Ministers. Berlin Declaration of the G20 Health Ministers: Together Today for a Healthy Tomorrow. Germany2017.

Dr Poonam Khetrapal Singh. Speech of the Regional Director: Workshop on National Action Plan on Antimicrobial Resistance for Developing Countries: Focusing on Resistance Emanating from Antibiotic Use in Food Animals. New Delhi, India: 34th session of WHO South-East Asia Advisory Committee on Health Research, World Health Organization 2016.

Parathon H, Kuntaman K, Widiastoety TH, Muliawan BT, Karuniawati A, Qibtiyah M, et al. Progress towards antimicrobial resistance containment and control in Indonesia. BMJ. 2017;358.

Yuliati D. Guidelines on Implementation of Antimicrobial Resistance Program in Indonesia (Landasan Pelaksanaan Program Pengendalian Resistensi Antimikroba di Indonesia). Simposium Nasional Upaya Peningkatan Kesadaran Pencegahan Penyakit dan Penggunaan Antimikroba yang Baik dan Benar :“More Protection, Less Antimicrobial”; Jakarta2018.

The Indonesian Ministry of Health. National Action Plan Antimicrobial Resistance Indonesia 2017-2019. 2017.

Indonesian Ministry of Health. Ministry of Health Regulation number 8 2015 Regarding Antimicrobial Resistant Control at Hospital Settings. 2015.

Indonesian Ministry of Health. Gema Cermat 2017 [Available from: http://farmalkes.kemkes.go.id/category/gemacermat/#.XAo5rNszb3g.

Cox JA, Vlieghe E, Mendelson M, Wertheim H, Ndegwa L, Villegas MV, et al. Antibiotic stewardship in low- and middle-income countries: the same but different? Clinical Microbiology and Infection. 2017;23(11):812-8.

Chee G, Borowitz M, Barraclough A. Private Health Care Sector in Indonesia. Bethesda, MD: Abt Associates Inc; 2009.

The Indonesian Ministry of Health. Riset Kesehatan Dasar (Riskesdas) 2013. 2013.

World Health Organization. Antibiotic Resistance: Multi-county Public Awareness Survey. 2015.

Indonesian Ministry of Health. Mapping of Pharmaceutical Facilities 2013 - 2016 (Aplikasi Pemetaan Sarana Kefarmasian 2013-2016) Jakarta 2017 [Available from: http://apif.binfar.depkes.go.id/index.php?req=view_services&p=pemetaanIndustriFarmasi.

World Bank. Pharmaceuticals : why reform is needed (English). Indonesia health sector review : policy and discussion notes. Washington, DC: World Bank; 2009.

Goodman C, Kachur SP, Abdulla S, Bloland P, Mills A. Drug shop regulation and malaria treatment in Tanzania--why do shops break the rules, and does it matter? Health policy and planning. 2007;22(6):393-403.

Hadi U, van den Broek P, Kolopaking EP, Zairina N, Gardjito W, Gyssens IC. Cross-sectional study of availability and pharmaceutical quality of antibiotics requested with or without prescription (Over The Counter) in Surabaya, Indonesia. BMC infectious diseases. 2010;10:203.

Editor Kompas. Jual Obat Tanpa Resep, Tiga Pemilik Toko Obat Ditangkap. Kompas. 2009.

Amaluddin. Dinkes akan Datangi Apotek Jual Bebas Antibiotik. Metrotvnews. 2015.

Baskoro D. Waspada Resistensi Antibiotik, Ketahui Fungsinya Sebelum Dikonsumsi. Okezone. 2016.

Arparsrithongsagul S, Kulsomboon V, Zuckerman IH. Multidisciplinary Perspective Intervention With Community Involvement to Decrease Antibiotic Sales in Village Groceries in Thailand. Asia Pacific Journal of Public Health. 2015;27(2):NP2480-NP8.

Om C, Daily F, Vlieghe E, McLaughlin JC, McLaws M-L. Pervasive antibiotic misuse in the Cambodian community: antibiotic-seeking behaviour with unrestricted access. Antimicrobial resistance and infection control. 2017;6:30-.

Okumura J, Wakai S, Umenai T. Drug utilisation and self-medication in rural communities in Vietnam. Social Science & Medicine. 2002;54(12):1875-86.

Presiden Republik Indonesia. Peraturan Pemerintah Republik Indonesia Nomor 51 Tahun 2009 tentang pekerjaan kefarmasian. Jakarta2009.

Sakeena MHF, Bennett AA, McLachlan AJ. Non-prescription sales of antimicrobial agents at community pharmacies in developing countries: a systematic review. International Journal of Antimicrobial Agents. 2018;52(6):771-82.

The Indonesian Ministry of Health. 86,10% masyarakat di Indonesia mendapatkan antibiotik tanpa resep dokter 2018 [Available from: https://twitter.com/KemenkesRI/status/1075669370 733350914.

Puspitasari HP, Faturrohmah A, Hermansyah A. Do Indonesian community pharmacy workers respond to antibiotics requests appropriately? Tropical medicine & international health : TM & IH. 2011;16(7):840-6.

Brata C, Marjadi B, Schneider CR, Murray K, Clifford RM. Information-gathering for self-medication via Eastern Indonesian community pharmacies: a cross-sectional study. BMC Health Serv Res. 2015;15:8.

Kotwani A, Wattal C, Joshi PC, Holloway K. Irrational use of antibiotics and role of the pharmacist: an insight from a qualitative study in New Delhi, India. Journal of Clinical Pharmacy and Therapeutics. 2012;37(3):308-12.

Kotwani A, Wattal C, Joshi PC, Holloway K. Irrational use of antibiotics and role of the pharmacist: an insight from a qualitative study in New Delhi, India. J Clin Pharm Ther. 2012;37(3):308-12.

Barker AK, Brown K, Ahsan M, Sengupta S, Safdar N. What drives inappropriate antibiotic dispensing? A mixed-methods study of pharmacy employee perspectives in Haryana, India. BMJ open. 2017;7(3).

Asharina I. Resistensi Antibiotic di Indonesia - Tak Usah Dulu Bermain Undang Undang. Bandung Institute of Technology 2016.


No Supplementary Material available for this article.
Article Views      : 249
PDF Downloads : 114